Ulcerative Colitis Medicine Market, Global Outlook and Forecast 2023-2029

Report ID: MMG9104 | Category: Service & Software | Pages: 60 | Format: PDF | Published Date: February 14,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Ulcerative Colitis Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ulcerative Colitis Medicine. This report contains market size and forecasts of Ulcerative Colitis Medicine in global, including the following market information:
Global Ulcerative Colitis Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ulcerative Colitis Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
5-Aminosalicylic Acid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ulcerative Colitis Medicine include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Cipla, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ulcerative Colitis Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ulcerative Colitis Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ulcerative Colitis Medicine Market Segment Percentages, by Type, 2022 (%)
    5-Aminosalicylic Acid
    Corticosteroids
    Immunomodulator Drugs
    Biologics
Global Ulcerative Colitis Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ulcerative Colitis Medicine Market Segment Percentages, by Application, 2022 (%)
    Ulcerative Proctitis
    Proctosigmoiditis
    Left-Sided Colitis
    Pancolitis
    Acute Severe Ulcerative Colitis
Global Ulcerative Colitis Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ulcerative Colitis Medicine Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ulcerative Colitis Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ulcerative Colitis Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sumitomo
    Pfizer
    Novartis
    Merck
    Sanofi
    Johnson and Johnson
    GSK
    AstraZeneca
    Cipla
    Sun Pharm
    Allergan
    Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ulcerative Colitis Medicine, market overview.
Chapter 2: Global Ulcerative Colitis Medicine market size in revenue.
Chapter 3: Detailed analysis of Ulcerative Colitis Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ulcerative Colitis Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Ulcerative Colitis Medicine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Ulcerative Colitis Medicine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Ulcerative Colitis Medicine Overall Market Size
    2.1 Global Ulcerative Colitis Medicine Market Size: 2022 VS 2029
    2.2 Global Ulcerative Colitis Medicine Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Ulcerative Colitis Medicine Players in Global Market
    3.2 Top Global Ulcerative Colitis Medicine Companies Ranked by Revenue
    3.3 Global Ulcerative Colitis Medicine Revenue by Companies
    3.4 Top 3 and Top 5 Ulcerative Colitis Medicine Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Ulcerative Colitis Medicine Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Medicine Players in Global Market
        3.6.1 List of Global Tier 1 Ulcerative Colitis Medicine Companies
        3.6.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Medicine Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Ulcerative Colitis Medicine Market Size Markets, 2022 & 2029
        4.1.2 5-Aminosalicylic Acid
        4.1.3 Corticosteroids
        4.1.4 Immunomodulator Drugs
        4.1.5 Biologics
    4.2 By Type - Global Ulcerative Colitis Medicine Revenue & Forecasts
        4.2.1 By Type - Global Ulcerative Colitis Medicine Revenue, 2018-2023
        4.2.2 By Type - Global Ulcerative Colitis Medicine Revenue, 2024-2029
        4.2.3 By Type - Global Ulcerative Colitis Medicine Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Ulcerative Colitis Medicine Market Size, 2022 & 2029
        5.1.2 Ulcerative Proctitis
        5.1.3 Proctosigmoiditis
        5.1.4 Left-Sided Colitis
        5.1.5 Pancolitis
        5.1.6 Acute Severe Ulcerative Colitis
    5.2 By Application - Global Ulcerative Colitis Medicine Revenue & Forecasts
        5.2.1 By Application - Global Ulcerative Colitis Medicine Revenue, 2018-2023
        5.2.2 By Application - Global Ulcerative Colitis Medicine Revenue, 2024-2029
        5.2.3 By Application - Global Ulcerative Colitis Medicine Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Ulcerative Colitis Medicine Market Size, 2022 & 2029
    6.2 By Region - Global Ulcerative Colitis Medicine Revenue & Forecasts
        6.2.1 By Region - Global Ulcerative Colitis Medicine Revenue, 2018-2023
        6.2.2 By Region - Global Ulcerative Colitis Medicine Revenue, 2024-2029
        6.2.3 By Region - Global Ulcerative Colitis Medicine Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Ulcerative Colitis Medicine Revenue, 2018-2029
        6.3.2 US Ulcerative Colitis Medicine Market Size, 2018-2029
        6.3.3 Canada Ulcerative Colitis Medicine Market Size, 2018-2029
        6.3.4 Mexico Ulcerative Colitis Medicine Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Ulcerative Colitis Medicine Revenue, 2018-2029
        6.4.2 Germany Ulcerative Colitis Medicine Market Size, 2018-2029
        6.4.3 France Ulcerative Colitis Medicine Market Size, 2018-2029
        6.4.4 U.K. Ulcerative Colitis Medicine Market Size, 2018-2029
        6.4.5 Italy Ulcerative Colitis Medicine Market Size, 2018-2029
        6.4.6 Russia Ulcerative Colitis Medicine Market Size, 2018-2029
        6.4.7 Nordic Countries Ulcerative Colitis Medicine Market Size, 2018-2029
        6.4.8 Benelux Ulcerative Colitis Medicine Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Ulcerative Colitis Medicine Revenue, 2018-2029
        6.5.2 China Ulcerative Colitis Medicine Market Size, 2018-2029
        6.5.3 Japan Ulcerative Colitis Medicine Market Size, 2018-2029
        6.5.4 South Korea Ulcerative Colitis Medicine Market Size, 2018-2029
        6.5.5 Southeast Asia Ulcerative Colitis Medicine Market Size, 2018-2029
        6.5.6 India Ulcerative Colitis Medicine Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Ulcerative Colitis Medicine Revenue, 2018-2029
        6.6.2 Brazil Ulcerative Colitis Medicine Market Size, 2018-2029
        6.6.3 Argentina Ulcerative Colitis Medicine Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, 2018-2029
        6.7.2 Turkey Ulcerative Colitis Medicine Market Size, 2018-2029
        6.7.3 Israel Ulcerative Colitis Medicine Market Size, 2018-2029
        6.7.4 Saudi Arabia Ulcerative Colitis Medicine Market Size, 2018-2029
        6.7.5 UAE Ulcerative Colitis Medicine Market Size, 2018-2029
7 Ulcerative Colitis Medicine Companies Profiles
    7.1 Sumitomo
        7.1.1 Sumitomo Company Summary
        7.1.2 Sumitomo Business Overview
        7.1.3 Sumitomo Ulcerative Colitis Medicine Major Product Offerings
        7.1.4 Sumitomo Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.1.5 Sumitomo Key News & Latest Developments
    7.2 Pfizer
        7.2.1 Pfizer Company Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Ulcerative Colitis Medicine Major Product Offerings
        7.2.4 Pfizer Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.2.5 Pfizer Key News & Latest Developments
    7.3 Novartis
        7.3.1 Novartis Company Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Ulcerative Colitis Medicine Major Product Offerings
        7.3.4 Novartis Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.3.5 Novartis Key News & Latest Developments
    7.4 Merck
        7.4.1 Merck Company Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Ulcerative Colitis Medicine Major Product Offerings
        7.4.4 Merck Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.4.5 Merck Key News & Latest Developments
    7.5 Sanofi
        7.5.1 Sanofi Company Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Ulcerative Colitis Medicine Major Product Offerings
        7.5.4 Sanofi Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.5.5 Sanofi Key News & Latest Developments
    7.6 Johnson and Johnson
        7.6.1 Johnson and Johnson Company Summary
        7.6.2 Johnson and Johnson Business Overview
        7.6.3 Johnson and Johnson Ulcerative Colitis Medicine Major Product Offerings
        7.6.4 Johnson and Johnson Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.6.5 Johnson and Johnson Key News & Latest Developments
    7.7 GSK
        7.7.1 GSK Company Summary
        7.7.2 GSK Business Overview
        7.7.3 GSK Ulcerative Colitis Medicine Major Product Offerings
        7.7.4 GSK Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.7.5 GSK Key News & Latest Developments
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Ulcerative Colitis Medicine Major Product Offerings
        7.8.4 AstraZeneca Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.8.5 AstraZeneca Key News & Latest Developments
    7.9 Cipla
        7.9.1 Cipla Company Summary
        7.9.2 Cipla Business Overview
        7.9.3 Cipla Ulcerative Colitis Medicine Major Product Offerings
        7.9.4 Cipla Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.9.5 Cipla Key News & Latest Developments
    7.10 Sun Pharm
        7.10.1 Sun Pharm Company Summary
        7.10.2 Sun Pharm Business Overview
        7.10.3 Sun Pharm Ulcerative Colitis Medicine Major Product Offerings
        7.10.4 Sun Pharm Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.10.5 Sun Pharm Key News & Latest Developments
    7.11 Allergan
        7.11.1 Allergan Company Summary
        7.11.2 Allergan Business Overview
        7.11.3 Allergan Ulcerative Colitis Medicine Major Product Offerings
        7.11.4 Allergan Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.11.5 Allergan Key News & Latest Developments
    7.12 Teva Pharmaceutical
        7.12.1 Teva Pharmaceutical Company Summary
        7.12.2 Teva Pharmaceutical Business Overview
        7.12.3 Teva Pharmaceutical Ulcerative Colitis Medicine Major Product Offerings
        7.12.4 Teva Pharmaceutical Ulcerative Colitis Medicine Revenue in Global Market (2018-2023)
        7.12.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Ulcerative Colitis Medicine Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?